Cargando…
Counterpoint: Postprandial Glucose Levels Are Not a Clinically Important Treatment Target
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909085/ https://www.ncbi.nlm.nih.gov/pubmed/20668159 http://dx.doi.org/10.2337/dc10-0712 |
_version_ | 1782184270972846080 |
---|---|
author | Davidson, Mayer B. |
author_facet | Davidson, Mayer B. |
author_sort | Davidson, Mayer B. |
collection | PubMed |
description | |
format | Text |
id | pubmed-2909085 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-29090852011-08-01 Counterpoint: Postprandial Glucose Levels Are Not a Clinically Important Treatment Target Davidson, Mayer B. Diabetes Care Point/Counterpoint American Diabetes Association 2010-08 /pmc/articles/PMC2909085/ /pubmed/20668159 http://dx.doi.org/10.2337/dc10-0712 Text en © 2010 by the American Diabetes Association. https://creativecommons.org/licenses/by-nc-nd/3.0/Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ (https://creativecommons.org/licenses/by-nc-nd/3.0/) for details. |
spellingShingle | Point/Counterpoint Davidson, Mayer B. Counterpoint: Postprandial Glucose Levels Are Not a Clinically Important Treatment Target |
title | Counterpoint: Postprandial Glucose Levels Are Not a Clinically Important Treatment Target |
title_full | Counterpoint: Postprandial Glucose Levels Are Not a Clinically Important Treatment Target |
title_fullStr | Counterpoint: Postprandial Glucose Levels Are Not a Clinically Important Treatment Target |
title_full_unstemmed | Counterpoint: Postprandial Glucose Levels Are Not a Clinically Important Treatment Target |
title_short | Counterpoint: Postprandial Glucose Levels Are Not a Clinically Important Treatment Target |
title_sort | counterpoint: postprandial glucose levels are not a clinically important treatment target |
topic | Point/Counterpoint |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909085/ https://www.ncbi.nlm.nih.gov/pubmed/20668159 http://dx.doi.org/10.2337/dc10-0712 |
work_keys_str_mv | AT davidsonmayerb counterpointpostprandialglucoselevelsarenotaclinicallyimportanttreatmenttarget |